Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@OncoThor Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::814218641579376641.png) @OncoThor Thor Halfdanarson

Thor Halfdanarson posts on X about all the, hills, lebanon, mayo the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::814218641579376641/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:interactions.svg)

- X Week XXXXX +1,116%
- X Months XXXXXX +35%
- X Year XXXXXXX +197%

### Mentions: X [#](/creator/twitter::814218641579376641/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:posts_active.svg)

- X Week X -XX%
- X Months XX -XX%
- X Year XX +332%

### Followers: XXXXX [#](/creator/twitter::814218641579376641/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:followers.svg)

- X Week XXXXX +0.60%
- X Months XXXXX +9.60%
- X Year XXXXX +17%

### CreatorRank: undefined [#](/creator/twitter::814218641579376641/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::814218641579376641/influence)
---

**Social category influence**
[countries](/list/countries)  XX% [stocks](/list/stocks)  XX%

**Social topic influence**
[all the](/topic/all-the) 25%, [hills](/topic/hills) 25%, [lebanon](/topic/lebanon) 25%, [mayo](/topic/mayo) 25%, [radar](/topic/radar) 25%, [threshold](/topic/threshold) XX%

**Top accounts mentioned or mentioned by**
[@rohitthum](/creator/undefined) [@dianereidylagun](/creator/undefined) [@lisabodei](/creator/undefined) [@natasharekhtman](/creator/undefined) [@anistoumeh](/creator/undefined) [@jacapdevila](/creator/undefined) [@rohit_thum](/creator/undefined)
### Top Social Posts [#](/creator/twitter::814218641579376641/posts)
---
Top posts by engagements in the last XX hours

"Another Mayo Clinic post-ASCO oncology conference wrapped up and as is now customary for me I celebrated a successful conference hitting the trails. Lebanon Hills in the Twin Cities has some great trails. Thanks to all the speakers attendees and supporters"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946725588892369138) 2025-07-20 00:15:23 UTC 5038 followers, XXX engagements


"On my NET PubMed radar this morning from @rohit_thum et al. at MSKCC. DLL3 positive in XX% of GEPNECs and XX% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out @lisabodei @DianeReidyLagun @natasharekhtman"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946188479005589987) 2025-07-18 12:41:06 UTC 5039 followers, 3374 engagements


"@rohit_thum @AnisToumeh @lisabodei @DianeReidyLagun @natasharekhtman I agree and second the comment on Amgen. We have treated a few pts with NECs but not yet a G3 NET patient but we are routinely staining for DLL3 now. Also agree with the comment on the DLL3 threshold. With obrixtamig XX% threshold may be reasonable right @Ja_Capdevila"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946214136783794270) 2025-07-18 14:23:03 UTC 5039 followers, XXX engagements


"@DianeReidyLagun @rohit_thum Agree there is a large unmet need for later lines of G3 pNETs and for refractory lung NETs. Trials needed for DLL3-targeting agents in these cohorts are definitely needed. Strong work Lots of goodies in the manuscript so NET folks check it out"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946190428006400117) 2025-07-18 12:48:51 UTC 5039 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@OncoThor Avatar @OncoThor Thor Halfdanarson

Thor Halfdanarson posts on X about all the, hills, lebanon, mayo the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX +1,116%
  • X Months XXXXXX +35%
  • X Year XXXXXXX +197%

Mentions: X #

Mentions Line Chart

  • X Week X -XX%
  • X Months XX -XX%
  • X Year XX +332%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.60%
  • X Months XXXXX +9.60%
  • X Year XXXXX +17%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence countries XX% stocks XX%

Social topic influence all the 25%, hills 25%, lebanon 25%, mayo 25%, radar 25%, threshold XX%

Top accounts mentioned or mentioned by @rohitthum @dianereidylagun @lisabodei @natasharekhtman @anistoumeh @jacapdevila @rohit_thum

Top Social Posts #


Top posts by engagements in the last XX hours

"Another Mayo Clinic post-ASCO oncology conference wrapped up and as is now customary for me I celebrated a successful conference hitting the trails. Lebanon Hills in the Twin Cities has some great trails. Thanks to all the speakers attendees and supporters"
@OncoThor Avatar @OncoThor on X 2025-07-20 00:15:23 UTC 5038 followers, XXX engagements

"On my NET PubMed radar this morning from @rohit_thum et al. at MSKCC. DLL3 positive in XX% of GEPNECs and XX% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out @lisabodei @DianeReidyLagun @natasharekhtman"
@OncoThor Avatar @OncoThor on X 2025-07-18 12:41:06 UTC 5039 followers, 3374 engagements

"@rohit_thum @AnisToumeh @lisabodei @DianeReidyLagun @natasharekhtman I agree and second the comment on Amgen. We have treated a few pts with NECs but not yet a G3 NET patient but we are routinely staining for DLL3 now. Also agree with the comment on the DLL3 threshold. With obrixtamig XX% threshold may be reasonable right @Ja_Capdevila"
@OncoThor Avatar @OncoThor on X 2025-07-18 14:23:03 UTC 5039 followers, XXX engagements

"@DianeReidyLagun @rohit_thum Agree there is a large unmet need for later lines of G3 pNETs and for refractory lung NETs. Trials needed for DLL3-targeting agents in these cohorts are definitely needed. Strong work Lots of goodies in the manuscript so NET folks check it out"
@OncoThor Avatar @OncoThor on X 2025-07-18 12:48:51 UTC 5039 followers, XXX engagements

@OncoThor
/creator/twitter::OncoThor